Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

Am I wrong to be apprehensive about gene therapy?

Is the introduction of gene therapy going to be smooth sailing? Origin's Strategic Solutions Director, Su Smith, shares her thoughts.

Bedrock Healthcare Communications

- PMLiVE

Healthcare communications in the mobile age

By Matt Royle

Patient Centricity On Trial

Today, 40 million patients are needed for over 300,00 clinical trials, worldwide. This year’s white paper explores how bringing the patient experience front and centre in clinical trials could revolutionise...

Havas Lynx

19 Patient Centricity on Trial

Clinical trials are broken and only patients can help us fix them. If we let them.

Havas Lynx

- PMLiVE

Novartis secures US approval – and payers’ blessing – for $2m gene therapy Zolgensma

Novel financing deal could be sector's future

- PMLiVE

European elections: Eurosceptics and Greens rise, but big parties hold on

Horse-trading over top jobs now begins

Novartis day

FDA clears Novartis’ new breast cancer drug Piqray

Blockbuster potential for PI3K drug

- PMLiVE

Resurgent Diurnal raises £5.4m for twin product filings

Company recovers after trial setback

Spotlight on innovation at life sciences forum

Paul Midgley, of Wilmington Healthcare, takes a look at the forthcoming HSJ Life Sciences Forum, where the NHS and industry will unite to discuss challenges and explore innovative solutions

Wilmington Healthcare

Pat Iannuzelli

Porterhouse Medical Group strengthens its US scientific team

The Porterhouse Medical Group announces a senior appointment at Porterhouse Medical US.

Porterhouse Medical Group

- PMLiVE

Embracing technology and analytics

By Diane Wass

- PMLiVE

Is it time for a more integrated and human-centric approach to Medical Affairs leadership?

By Shairose Ebrahim

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links